Aethlon Medical (AEMD) vs Fractyl Health (GUTS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Fractyl Health is the larger company by market cap ($10.9 million vs $8.8 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AEMD | GUTS |
|---|---|---|
| Share price | $5.46 | $0.82 |
| Market cap | $8.78M | $10.88M |
| 1-day change | +12.81% | -14.16% |
| YTD return | — | -96.89% |
| 1-year return | — | -95.12% |
| EPS (TTM) | $-16.22 | $-3.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $0 |
| Revenue growth (YoY) | — | -100.00% |
| Net income (latest FY) | $-7.15M | $-140.95M |
| 52-week high | $24.75 | $29.34 |
| 52-week low | $1.41 | $0.784 |
| Distance from 52-week high | -77.94% | -97.21% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +142.67% | +7265.85% |
| Average volume | 2.56M | 504.39K |
| Shares outstanding | 1.61M | 13.26M |
| Employees | 9 | 100 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Aethlon Medical
AEMD stock →Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states.
Health Care · Medical/Dental Instruments · 9 employees
About Fractyl Health
GUTS stock →Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.
Health Care · Medical/Dental Instruments · 100 employees
AEMD vs GUTS FAQ
Which is bigger, Aethlon Medical or Fractyl Health?
Fractyl Health (GUTS) is larger, with a market capitalization of $10.88M compared with $8.78M for Aethlon Medical (AEMD).
Are Aethlon Medical and Fractyl Health in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.